In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...